Maternal cumulative exposure to extremely low frequency electromagnetic fields, prematurity and small for gestational age: a pooled analysis of two birth cohorts.


Journal

Occupational and environmental medicine
ISSN: 1470-7926
Titre abrégé: Occup Environ Med
Pays: England
ID NLM: 9422759

Informations de publication

Date de publication:
01 2020
Historique:
received: 22 02 2019
revised: 12 08 2019
accepted: 06 11 2019
entrez: 14 12 2019
pubmed: 14 12 2019
medline: 29 4 2020
Statut: ppublish

Résumé

Data on the effects of extremely low frequency electromagnetic fields (ELF-EMF) on pregnancy outcomes are inconclusive. To study the relation between maternal cumulative exposure to ELF-EMF during pregnancy and the risk of prematurity or small for gestational age (SGA) in a pooled analysis of two French birth cohorts. Elfe and Epipage2 are both population-based birth cohorts initiated in 2011 and included 18 329 and 8400 births, respectively. Health data and household, mother and child characteristics were obtained from medical records and questionnaires at maternity and during follow-up. A job exposure matrix was used to assess cumulative exposure to ELF-EMF during three periods: (1) until 15 weeks of gestation, (2) until 28 weeks of gestation and (3) until 32 weeks of gestation. Analyses were restricted to single live births in mainland France and to mothers with documented jobs (N=19 894). Adjusted logistic regression models were used. According to the period studied, 3.2%-4% of mothers were classified as highly exposed. Results were heterogeneous. Increased risks of prematurity were found among low exposed mothers for the three periods, and no association was observed among the most exposed (OR Some heterogeneous associations between ELF-EMF exposure and prematurity and SGA were observed. However, due to heterogeneity (ie, their independence regarding the level of exposure), associations cannot be definitely explained by ELF-EMF exposure.

Sections du résumé

BACKGROUND
Data on the effects of extremely low frequency electromagnetic fields (ELF-EMF) on pregnancy outcomes are inconclusive.
OBJECTIVE
To study the relation between maternal cumulative exposure to ELF-EMF during pregnancy and the risk of prematurity or small for gestational age (SGA) in a pooled analysis of two French birth cohorts.
METHODS
Elfe and Epipage2 are both population-based birth cohorts initiated in 2011 and included 18 329 and 8400 births, respectively. Health data and household, mother and child characteristics were obtained from medical records and questionnaires at maternity and during follow-up. A job exposure matrix was used to assess cumulative exposure to ELF-EMF during three periods: (1) until 15 weeks of gestation, (2) until 28 weeks of gestation and (3) until 32 weeks of gestation. Analyses were restricted to single live births in mainland France and to mothers with documented jobs (N=19 894). Adjusted logistic regression models were used.
RESULTS
According to the period studied, 3.2%-4% of mothers were classified as highly exposed. Results were heterogeneous. Increased risks of prematurity were found among low exposed mothers for the three periods, and no association was observed among the most exposed (OR
CONCLUSION
Some heterogeneous associations between ELF-EMF exposure and prematurity and SGA were observed. However, due to heterogeneity (ie, their independence regarding the level of exposure), associations cannot be definitely explained by ELF-EMF exposure.

Identifiants

pubmed: 31831625
pii: oemed-2019-105785
doi: 10.1136/oemed-2019-105785
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

22-31

Informations de copyright

© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Lucile Migault (L)

University of Bordeaux, Inserm UMR 1219 EPICENE Team, Bordeaux Population Health Research Center, Bordeaux, France.

Ronan Garlantézec (R)

Université de Rennes, Inserm, CHU, EHESP, Irset (Institut de recherche en santé, environnement et travail) - UMR_S 1085, Rennes, France.

Clément Piel (C)

University of Bordeaux, Inserm UMR 1219 EPICENE Team, Bordeaux Population Health Research Center, Bordeaux, France.

Laetitia Marchand-Martin (L)

Inserm U1153, Obstetric, Perinatal and Paediatric Epidemiology, Sorbonne Paris Cité, 'Risks in pregnancy' University Hospital Department, Paris, France.

Sébastien Orazio (S)

University of Bordeaux, Inserm UMR 1219 EPICENE Team, Bordeaux Population Health Research Center, Bordeaux, France.
Registre des Hémopathies Malignes de la Gironde, Institut Bergonié, Bordeaux, France.

Marie Cheminat (M)

Joint Research Unit Elfe, Ined-Inserm-EFS, Paris, France.

Cécile Zaros (C)

Joint Research Unit Elfe, Ined-Inserm-EFS, Paris, France.

Camille Carles (C)

University of Bordeaux, Inserm UMR 1219 EPICENE Team, Bordeaux Population Health Research Center, Bordeaux, France.
Bordeaux University Hospital, Service de Médecine du Travail et Pathologies Professionnelles, Bordeaux, France.

Elisabeth Cardis (E)

Barcelona Institute for Global Health (ISGlobal), Universitat Pompeu Fabra, Barcelona, Spain.
CIBER Epidemiologia y Salud Pública (CIBERESP), Madrid, Spain.

Pierre-Yves Ancel (PY)

Inserm U1153, Obstetric, Perinatal and Paediatric Epidemiology, Sorbonne Paris Cité, 'Risks in pregnancy' University Hospital Department, Paris, France.
Université Paris Descartes, Cochin-Port Royal Hospital, AP-HP, Paris, France.

Marie-Aline Charles (MA)

Joint Research Unit Elfe, Ined-Inserm-EFS, Paris, France.
Center for Epidemiology and Statistics Sorbonne Paris Cité, INSERM UMR1153, Team: Early Origin of the Child's Health and Development, Paris Descartes University, Villejuif, France.

René de Seze (R)

TOXI PERITOX UMR-I-01 Unit, INERIS, Verneuil-en-Halatte, France.

Isabelle Baldi (I)

University of Bordeaux, Inserm UMR 1219 EPICENE Team, Bordeaux Population Health Research Center, Bordeaux, France.
Bordeaux University Hospital, Service de Médecine du Travail et Pathologies Professionnelles, Bordeaux, France.

Ghislaine Bouvier (G)

University of Bordeaux, Inserm UMR 1219 EPICENE Team, Bordeaux Population Health Research Center, Bordeaux, France ghislaine.bouvier@u-bordeaux.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH